Sun Pharma inks licensing pact with AstraZeneca to introduce products in China

This comes after AstraZeneca said it was launching a new fund with China International Capital Corp to invest $1 billion in China#39;s healthcare sector, as it expands its research work in the country.

from Moneycontrol Business News https://ift.tt/32mmuQ3